Skip to main content
. 2020 Apr 16;2020(4):CD013581. doi: 10.1002/14651858.CD013581

Agrifoglio 1994.

Methods RCT; multicentre, single‐blind (observer blind), randomised, parallel group study Randomization procedure not described
Follow‐up time: 8 days
Participants Population: 100 participants, 40 women, 60 men. Mean age 42.2 years (range 19 to 68)
Setting: enrolled from 5 centres in Italy
Inclusion criteria: acute lumbago, onset less than 48 hours ago, age 18 to 70 years, pain intensity at least 50 mm on VAS
Exclusion criteria: any disorder which might interfere with the study drug, usage of anticoagulants or other drugs which may interfere with the treatment assessment, pregnancy, breastfeeding, or hormonal contraception
Interventions NSAID (i): aceclofenac 150 mg IM b.i.d. for 2 days + 100 mg tablets b.i.d. for 5 days + 1 placebo tablet for 5 days (N = 50)
 NSAID (ii): diclofenac 75 mg IM b.i.d. for 2 days + 50 mg tablets t.i.d. for 5 days (N = 50)
Outcomes Mean improvement in pain intensity (VAS; 0 to 100 mm) after 8 days: (i) 65 (ii) 62
Global improvement good/very good in (i) 87% and (ii) 79% of participants
Adverse events: (i) 1 (ii) 6 participants
Funding Not mentioned
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomisation procedure not described
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel (performance bias) 
 All outcomes ‐ participants Unclear risk Not mentioned
Blinding of participants and personnel (performance bias) 
 All outcomes ‐ careproviders Unclear risk Not mentioned
Blinding of outcome assessment (detection bias) 
 All outcomes ‐ outcome assessors Unclear risk Not mentioned
Incomplete outcome data (attrition bias) 
 All outcomes ‐ dropouts Low risk (i) 9/50 withdrew = 18%
(ii) 8/50 withdrew = 16%
Incomplete outcome data (attrition bias) 
 All outcomes ‐ ITT analysis Unclear risk No ITT analysis mentioned
Selective reporting (reporting bias) Unclear risk No study protocol
Similarity at baseline characteristics Low risk Baseline characteristics similar
Co‐interventions avoided or similar Unclear risk Not mentioned
Compliance acceptable Unclear risk Not mentioned
Timing outcome assessments similar Low risk Timing similar
Other bias Low risk None